SBNO2 (strawberry notch homolog 2) functions as a transcriptional coregulator with both coactivator and corepressor activities across multiple biological contexts. In hematopoietic malignancies, SBNO2 serves as a critical mediator downstream of STAT3 signaling, where it acts as an essential transcriptional target of oncogenic STAT3Y640F mutations in large granular lymphocytic leukemia and other STAT3-driven cancers 1. The gene demonstrates tissue-specific expression patterns, being upregulated in glioblastoma compared to normal brain tissue and lower-grade gliomas 2. SBNO2 plays important roles in inflammatory responses, functioning as an acute inflammatory response gene in astrocytes and other CNS cells following lipopolysaccharide stimulation 3. The gene shows differential isoform regulation, with disease-associated quantitative trait loci affecting isoform 2 expression, which specifically impacts antimicrobial activity in macrophages and links to Crohn's disease susceptibility 4. Additionally, SBNO2 expression correlates with immune cell infiltration and is associated with poor prognosis in gastric cancer 5. In bone metabolism, SBNO2 appears to contribute to osteoporosis development in male ankylosing spondylitis patients 6, while also being implicated in atopic dermatitis through CD4+ tissue resident memory cells 7.